Surfactant protein-A inhibits thymic stromal lymphopoietin-mediated T follicular helper cell differentiation and IgE production in asthma

Minghui Xue,Shuqin Xu,Li Su,Siwei He,Beiying Wu,Cunpeng Ji,Lin Lin,Xiaomeng Nie,Gang Cai
DOI: https://doi.org/10.1016/j.clim.2021.108822
IF: 10.19
2021-10-01
Clinical Immunology
Abstract:Lung surfactant protein A (SP-A) is critical for immunomodulation. Thymic stromal lymphopoietin (TSLP)-activated dendritic cells (DCs) drive T follicular helper (Tfh) cells differentiation in allergic asthma. We employed wild-type (WT) and SP-A<sup>-/-</sup> mice injected with TSLP and ovalbumin (OVA)-activated DCs and challenged with OVA. Compared with WT mice, we showed that allergic inflammation was dramatically increased in SP-A<sup>-/-</sup> mice. In parallel, both IL-4-producing CD45RA<sup>-</sup>CXCR5<sup>+</sup>PD-1<sup>+</sup>CD4<sup>+</sup> cells (Tfh2) and IgE were markedly increased in SP-A<sup>-/-</sup> mice. Further study showed that SP-A prohibited TSLP activated-DCs from expressing OX40L. When we blocked OX40L-OX40 and IL-4R signaling, the differentiation of Tfh2 and IgE responses in SP-A<sup>-/-</sup> mice was significantly inhibited. In severe asthma patients, SP-A is dysfunctional in modulating the TSLP-DCs-mediated differentiation of Tfh cells. This study suggests that SP-A acts as a modulator of Tfh differentiation and IgE generation in asthma.
immunology
What problem does this paper attempt to address?